1. |
Lin R, Chen F, Wen S, et al. Interleukin-10 attenuates impairment of the blood-brain barrier in a severe acute pancreatitis rat model. J Inflamm (Lond), 2018, 15: 4.
|
2. |
Liu MW, Wei R, Su MX, et al. Effects of Panax notoginseng saponins on severe acute pancreatitis through the regulation of mTOR/Akt and caspase-3 signaling pathway by upregulating miR-181b expression in rats. BMC Complement Altern Med, 2018, 18(1): 51.
|
3. |
Ramudo L, Yubero S, Manso MA, et al. Signal transduction of MCP-1 expression induced by pancreatitis-associated ascitic fluid in pancreatic acinar cells. J Cell Mol Med, 2009, 13(7): 1314-1320.
|
4. |
Rijkers AP, van Eijck CH. Acute pancreatitis. N Engl J Med, 2017, 376(6): 596-597.
|
5. |
Zerem E. Treatment of severe acute pancreatitis and its complications. World J Gastroenterol, 2014, 20(38): 13879-13892.
|
6. |
Abulimiti A, Husaiyin A, Sailai Y. Evaluation of HVHF for the treatment of severe acute pancreatitis accompanying MODS. Medicine (Baltimore), 2018, 97(1): e9417.
|
7. |
Beger HG, Rau B, Mayer J, et al. Natural course of acute pancreatitis. World J Surg, 1997, 21(2): 130-135.
|
8. |
Büchler MW, Gloor B, Müller CA, et al. Acute necrotizing pancreatitis: treatment strategy according to the status of infection. Ann Surg, 2000, 232(5): 619-626.
|
9. |
隆艳艳, 焦顺昌. mTOR 抑制剂对炎症相关细胞因子分泌的影响. 解放军医学院学报, 2015, 36(12): 1252-1254, 1265.
|
10. |
Engelmann C, Weih F, Haenold R. Role of nuclear factor kappa B in central nervous system regeneration. Neural Regen Res, 2014, 9(7): 707-711.
|
11. |
Shi G, Li D, Li X, et al. mTOR inhibitor INK128 attenuates systemic lupus erythematosus by regulating inflammation-induced CD11b. Biochim Biophys Acta Mol Basis Dis, 2019, 1865(1): 1-13.
|
12. |
谭家华, 付海荣, 秦伟. 新 mTOR 抑制剂洋椿苦素对骨关节炎的保护作用及机制研究. 重庆医科大学学报, 2018, 43(10): 1324-1331.
|
13. |
Wang X, Chu L, Liu C, et al. Therapeutic effects of Saussurea involucrata injection against severe acute pancreatitis- induced brain injury in rats. Biomed Pharmacother, 2018, 100: 564-574.
|
14. |
Laukkarinen JM, Van Acker GJ, Weiss ER, et al. A mouse model of acute biliary pancreatitis induced by retrograde pancreatic duct infusion of Na-taurocholate. Gut, 2007, 56(11): 1590-1598.
|
15. |
Gorelick FS, Lerch MM. Do animal models of acute pancreatitis reproduce human disease? Cell Mol Gastroenterol Hepatol, 2017, 4(2): 251-262.
|
16. |
吉九威, 赵海平, 胡文秀, 等. 亚甲蓝+牛磺胆酸钠联合逆行胰胆管注射法制备重症急性胰腺炎大鼠模型. 中国普外基础与临床杂志, 2018, 25(9): 1049-1054.
|
17. |
Schmidt J, Rattner DW, Lewandrowski K, et al. A better model of acute pancreatitis for evaluating therapy. Ann Surg, 1992, 215(1): 44-56.
|
18. |
Horvath K, Freeny P, Escallon J, et al. Safety and efficacy of video-assisted retroperitoneal debridement for infected pancreatic collections: a multicenter, prospective, single-arm phase 2 study. Arch Surg, 2010, 145(9): 817-825.
|
19. |
Beger HG, Rau BM. Severe acute pancreatitis: clinical course and management. World J Gastroenterol, 2007, 13(38): 5043-5051.
|
20. |
Bruennler T, Langgartner J, Lang S, et al. Outcome of patients with acute, necrotizing pancreatitis requiring drainage-does drainage size matter? World J Gastroenterol, 2008, 14(5): 725-730.
|
21. |
Lerch MM, Gorelick FS. Models of acute and chronic pancreatitis. Gastroenterology, 2013, 144(6): 1180-1193.
|
22. |
Jacinto E. What controls TOR? IUBMB Life, 2008, 60(8): 483-496.
|
23. |
Alessi DR, Pearce LR, García-Martínez JM. New insights into mTOR signaling: mTORC2 and beyond. Sci Signal, 2009, 2(67): pe27.
|
24. |
Ma XM, Blenis J. Molecular mechanisms of mTOR-mediated translational control. Nat Rev Mol Cell Biol, 2009, 10(5): 307-318.
|
25. |
Zhan W, Lin S, Chen J, et al. Design, synthesis, biological evaluation, and molecular docking of novel benzopyran and phenylpyrazole derivatives as Akt inhibitors. Chem Biol Drug Des, 2015, 85(6): 770-779.
|
26. |
Ma X, Lv X, Qiu N, et al. Discovery of novel quinoline-based mTOR inhibitors via introducing intra-molecular hydrogen bonding scaffold (iMHBS): the design, synthesis and biological evaluation. Bioorg Med Chem, 2015, 23(24): 7585-7596.
|
27. |
Xia Z, Gao T, Zong Y, et al. Evaluation of subchronic toxicity of GRD081, a dual PI3K/mTOR inhibitor, after 28-day repeated oral administration in Sprague-Dawley rats and beagle dogs. Food Chem Toxicol, 2013, 62(12): 687-698.
|
28. |
Bhaskar PT, Hay N. The two TORCs and Akt. Dev Cell, 2007, 12(4): 487-502.
|
29. |
Julien LA, Carriere A, Moreau J, et al. mTORC1-activated S6K1 phosphorylates Rictor on threonine 1 135 and regulates mTORC2 signaling. Mol Cell Biol, 2010, 30(4): 908-921.
|